Corcept Therapeutics (CORT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $121.05 +1.71%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q3 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $13.3 million versus the consensus estimate of $13.9 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
